A. Kasmia, M.Sc., M.D.

Baldwin Neurology, LLC, 188 Hospital drive Suite 300, Fairhope, Al 36532.

Phone (251)-990-1910, Fax (251)-990-1911

About us Links Contact US Services News 

Neurology news

Botox in the treatment of headaches: (Coming soon!)

Patients with transformed migraine have lower pain tolerance:

Some studies have revealed that patients with transformed migraines (more than 15 days/month) are more sensitive to pain than patients with episodic migraines. This may explain why some of these patients seem to have less responsiveness to the usual migraine medications( sumatriptan for example).  One study was presented by Dr. Kitsaj at the American Academy of Neurology Annual Meeting in 2004 .  More studies are needed to better understand this phenomenon and its implications in headache management  CNS News

Zomig (Zolmitriptan) Nasal Spray Demonstrates Rapid Onset of Migraine Relief

Zolmitriptan (Zomig) study showed a faster response of a nasal spray preparation compared to placebo.  Although the study used 2 hour as a therapeutic efficacy time window, the nasal spray was also found to be more efficacious at 15 minutes, 30 minutes and 1 hour compared to placebo. ACHE

Chronic daily headaches are more common in obese individuals

Dr. Lipton's group has studied the impact of body mass index ( obesity) on chronic daily headaches frequency, severity and disability.  The prevalence of chronic daily headaches was found to be higher among obese individuals than normal weight individuals.   More obese groups have the highest prevalence.  One more reason to control your weight!.  Ref: See full story in  AAN 57the Annual Meeting supplement to neurology Volume 64, Number 6, supplemt1 S59.00

Home    Services    News    About us    Neuro pictures       Links    Contact us